Press Releases

All Releases
View Summary Ironwood Pharmaceuticals Announces Conference Call to Discuss Positive Linaclotide Phase 3 IBS-C Results
Sep 13, 2010
PDF 13.4 KB Add to Briefcase
View Summary Ironwood and Forest Announce Positive Linaclotide Results from Phase 3 Trial in Patients with Irritable Bowel Syndrome with Constipation
Sep 13, 2010
PDF 23.7 KB Add to Briefcase
View Summary Almirall and Ironwood Announce Positive Results from a Phase 3 Trial with Linaclotide in Patients with Irritable Bowel Syndrome with Constipation
Sep 13, 2010
PDF 23.7 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Announces Upcoming Presentation at Morgan Stanley Global Healthcare Conference
Sep 9, 2010
PDF 13.0 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Provides Second Quarter 2010 Investor Update
Aug 5, 2010
PDF 22.9 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Announces Second Quarter 2010 Investor Update Call
Aug 2, 2010
PDF 13.3 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Announces Upcoming Presentation at Wedbush Life Sciences MAC Best Ideas 2010
Jul 28, 2010
PDF 13.0 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Announces Participation in J.P. Morgan Biotech CEO/CFO Conference Call
May 26, 2010
PDF 12.8 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Provides First Quarter 2010 Investor Update
May 11, 2010
PDF 23.4 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Announces First Quarter 2010 Investor Update Call and Upcoming Presentation at Bank of America Merrill Lynch 2010 Health Care Conference
May 7, 2010
PDF 14.0 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Files Annual Report on Form 10-K
Mar 30, 2010
PDF 13.2 KB Add to Briefcase
View Summary Underwriters Exercise Over-Allotment Option for Ironwood Pharmaceuticals' Initial Public Offering
Feb 16, 2010
PDF 16.2 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Files Registration Statement for Initial Public Offering
Nov 20, 2009
PDF 12.6 KB Add to Briefcase
View Summary Ironwood and Astellas Announce Japan Licensing Agreement for Linaclotide
Nov 10, 2009
PDF 14.1 KB Add to Briefcase
View Summary Ironwood and Forest Announce Positive Linaclotide Results from Two Pivotal Phase 3 Trials In Patients with Chronic Constipation
Nov 2, 2009
PDF 20.7 KB Add to Briefcase
View Summary Marsha Fanucci Joins Ironwood Board of Directors
Oct 27, 2009
PDF 12.4 KB Add to Briefcase
View Summary Ironwood Appoints Thomas McCourt as Chief Commercial Officer and Senior Vice President of Marketing and Sales
Sep 14, 2009
PDF 12.5 KB Add to Briefcase
View Summary David Ebersman Joins Ironwood Board of Directors
Sep 14, 2009
PDF 12.2 KB Add to Briefcase
View Summary Ironwood And Forest Present Additional Positive Phase 2b Study Results For Linaclotide In Patients With Irritable Bowel Syndrome With Constipation
May 31, 2009
PDF 20.7 KB Add to Briefcase
View Summary Ironwood And Forest To Present Additional Phase 2b Data For Novel Gastrointestinal Agent Linaclotide
May 12, 2009
PDF 17.7 KB Add to Briefcase
Showing 221-240 of 250 Page: 1 ... 8 9 10 11 12 13  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase
You are now leaving ironwoodpharma.com. This link will take you to
a website to which our privacy policy does not apply. You are solely
responsible for your interactions with that website.